Specify a stock or a cryptocurrency in the search bar to get a summary
Japan Tissue Engineering Co Ltd
7774Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited. Address: 6-209-1 Miyakitadori, Gamagori, Japan, 443-0022
Analytics
WallStreet Target Price
182 848.56 JPYP/E ratio
141.1268Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 7774
Dividend Analytics 7774
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 7774
Stock Valuation 7774
Financials 7774
Results | 2019 | Dynamics |